FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
BIMI International Medical Inc. Stock AnalysisComprehensive stock analysis for BIMI International Medical Inc. (BIMI) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisBIMI
BIMI
BIMI International Medical Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
BIMI
Home🔹Stocks🔹BIMI International Medical Inc.

BIMI International Medical Inc.

🇺🇸BIMI•OTC

BIMI International Medical Inc.

🇺🇸BIMI•OTC
Market cap
$1.16K
Sentiment

Your view on BIMI

Mkt Cap
$1.16K
Sentiment
Your view
BIMI
BIMI International Medical Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
BIMI
Company Overview

Overview

What the company does, where it operates, and who runs it.

About BIMI International Medical Inc.

Industry
Medical - Distribution
Sector
Healthcare
CEO
Tiewei Song
Headquarters
Chongqing Corporation Avenue, Chongqing, CN
Industry
Medical - Distribution
Sector
Healthcare
CEO
Tiewei Song
Headquarters
Chongqing Corporation Avenue, Chongqing, CN
Description

BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China.

The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies.

It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China.

The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines.

In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name.

Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021.

BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People's Republic of China.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for BIMI International Medical Inc., and the rating behind it. BIMI last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for BIMI International Medical Inc.. Starting points for BIMI International Medical Inc.: EPS -$8.40, beta -0.68 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for BIMI International Medical Inc.. BIMI International Medical Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for BIMI International Medical Inc.. Trailing twelve-month EPS for BIMI International Medical Inc. stands at -$8.40. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for BIMI International Medical Inc.. BIMI International Medical Inc. has reported as a listed company since 2006. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

BIMI International Medical Inc. valued side by side against its closest peers. BIMI International Medical Inc. is measured against Medical - Distribution peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold BIMI International Medical Inc., and how their positions are changing. At a $1,156 market value, institutional positions materially move BIMI International Medical Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by BIMI International Medical Inc. executives and directors. Shares of BIMI International Medical Inc. have traded between $0.0001 and $0.01 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming BIMI International Medical Inc.. BIMI International Medical Inc. is a $1,156 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming BIMI International Medical Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for BIMI International Medical Inc.. Coverage tracks BIMI International Medical Inc. within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • ADYX — Adynxx, Inc.
  • BGMD — BG Medicine, Inc.
  • CFRXQ — ContraFect Corporation
  • EFTR — eFFECTOR Therapeutics, Inc.
  • FSPM — FusionPharm, Inc.
  • GRPI — Grupo International Inc.
  • IMVIF — IMV Inc.

More Medical - Distribution companies

  • SHTDY — Sinopharm Group Co. Ltd.
  • SIG.AX — Sigma Healthcare Limited
  • SNYR — Synergy CHC Corp.
  • SZUKF — Suzuken Co., Ltd.
  • YI — 111, Inc.
  • ZHYBF — Zhong Yuan Bio-Technology Holdings Limited
  • ZRSEF — DocMorris AG
  • AHG — Akso Health Group
  • AIXN — AiXin Life International, Inc.
  • ALFRY — Alfresa Holdings Corporation
  • AMFPF — Amplifon S.p.A.
  • ARHCF — Alfresa Holdings Corporation

News

Latest Market News